Company intelligence / Profile preview
Avicanna
Toronto, Ontario, Canadaavicanna.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Avicanna has commercialized over thirty proprietary cannabinoid-based finished products across medical cannabis and wellness markets. Its pharmaceutical pipeline includes indication-specific candidates in various clinical stages targeting dermatology, chronic pain, and neurological disorders. The company recently reported its first profitable quarter in Q1 of 2025 and completed its first product deliveries into Europe under a supply agreement with a multinational pharmaceutical partner. Its SEDDS technology enhances oral bioavailability of cannabinoids.
- Therapeutic areas
- DermatologyNeurology
- Modalities
- Small molecule (cannabinoids such as CBD, CBG, THC)Topical formulationOral formulationSublingual formulationTransdermal formulationSelf-emulsifying drug delivery system (SEDDS)
- Industry
- Biotech
02
Drug pipeline
11 assets10 more assets in the full pipeline.
03
Partnerships
Multinational pharmaceutical company for European distribution/supply agreementVectura Fertin Pharma collaboration for scientific & medical affairsacademic partnerships with University Health Network (“UHN”), Odette Cancer Centre/Sunnybrook Health Science Centre
Beyond the preview
Go deeper on Avicanna.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Avicanna.